[ Price : $8.95]
Taxpayers Protection Alliance executive director Ross Marchand says FDA needs to change its risk-averse approach to drug evaluatio...[ Price : $8.95]
FDA warns Winder, GA-based Winder Laboratories about repeat CGMP violations in its manufacturing of finished drugs.[ Price : $8.95]
FDA accepts for priority review an Argenx supplemental BLA seeking to expand the use of its myasthenia gravis drug Vyvgart.[ Price : $8.95]
An Ars Technica post says FDA has dropped a Web page that listed some specific bogus autism treatments and therapies and warned of...[ Price : $8.95]
The National Security Commission on Emerging Biotechnology recommends 22 policy actions in five key areas to modernize FDA medical...[ Price : $8.95]
FDA accepts for review a PharmaEssentia supplemental BLA seeking to expand the label of its interferon therapy Besremi to include ...[ Price : $8.95]
Former FDA Oncology Center for Excellence director Richard Pazdur warns that political interference and internal upheaval are erod...[ Price : $8.95]
FDA extends by three months its review of a Travere Therapeutics supplemental NDA for Filspari in focal segmental glomeruloscleros...